蓝芩口服液联合干扰素雾化吸入治疗小儿疱疹性咽峡炎

Inhalation of Lanqin Oral Solutions Combined with Interferon in the Treatment of Children with Herpes Angina

目的:观察蓝芩口服液联合干扰素雾化吸入治疗小儿疱疹性咽峡炎的临床疗效和安全性。方法:疱疹性咽峡炎患儿随机分为两组,在支持治疗的基础上,对照组(57例)予利巴韦林静滴,观察组(58例)口服蓝芩口服液联合干扰素雾化吸入。观察比较两组临床症状消失时间及治疗总有效率和药品不良反应。结果:观察组症状消失时间较对照组明显缩短(P<0.05),治疗总有效率明显优于对照组(P<0.05)。两组药品不良反应均少而轻微。讨论:蓝芩口服液联合干扰素雾化吸入治疗小儿疱疹性咽峡炎疗效肯定,临床症状消失快,使用方便,且安全性好,值得临床推广应用。

Objective： To observe the effect and safety of the inhalation of Lanqin oral solutions combined with interferon in the treatment of children herpes angina. Methods： The children with herpes angina were randomly divided into two groups. On the basis of support treatment,the control group（ 57 cases） was intravenously treated with ribavirin,and the observation group（ 58 cases） was treated with the combined inhalation of interferon and Lanqin oral solutions. The time of transference cure,total efficiency and adverse drug reactions in the two groups were observed and compared. Results： The time of transference cure of the observation group was significantly shorter than that of the control group（ P 0. 05） with higher total efficiency（ P 0. 05）. The adverse drug reactions were few and mild in the two groups. Conclusion： The inhalation of Lanqin oral solutions combined with interferon in the treatment of children with herpes angina is effective with short transference cure time,convenience of use and promising security,which is worthy of clinical application.